Partner Headlines - INFI

  1. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  2. Pharmacyclics Price Target Cut On Higher Spending

    IBD
  3. Benzinga's Top Upgrades

    Benzinga
  4. JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform

    Benzinga
  5. Infinity, AbbVie team on drug

    IBD
  6. S&P 500 Struggles To Hold 2,000 As Commodities Rebound

    Benzinga
  7. Midday Gainers From Wednesday, September 3

    Benzinga
  8. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD
  9. NASDAQ Tumbles 0.5%; Infinity Pharmaceuticals Jumps On Deal With ...

    Benzinga
  10. Markets Gain; Toll Brothers Profit Beats Estimates

    Benzinga
  11. Benzinga's Volume Movers

    Benzinga
  12. Morning Market Movers

    Benzinga
  13. Stock Futures Up And Climbing; Baidu Heads China Stock Rally

    IBD
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. What You Need to Know About the Roche-InterMune Deal

    Benzinga
  16. Markets Open Higher; Burger King In Talks To Buy Tim Hortons

    Benzinga
  17. InterMune's Roche Deal Sends Peer Group Up

    Benzinga
  18. 3 Small-Cap Biotechs That Institutions Are Loving

    Benzinga
  19. UPDATE: Morgan Stanley Initiates Coverage On Infinity Pharmaceuticals ...

    Benzinga
  20. The Top Five Drug Launches Of 2013

    IBD
  21. UPDATE: Credit Suisse Downgrades Infinity Pharmaceuticals on ...

    Benzinga
  22. Benzinga's Top Downgrades

    Benzinga
  23. Celgene's stock hits new high

    IBD
  24. Mid-Day Market Update: Sysco Shares Rise Following Merger with ...

    Benzinga
  25. Celgene, Infinity Rise On Blood Cancer Drug Data

    IBD
  26. Benzinga's Volume Movers

    Benzinga
  27. Infinity Reports Encouraging Phase 1 IPI-145 Data at ASH

    Benzinga
  28. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ...

    Benzinga
  29. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ...

    Benzinga
  30. UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals ...

    Benzinga
  31. Benzinga's Top Initiations

    Benzinga
  32. The Best Small Cap Performers of 2012

    Benzinga
  33. Stocks Hitting 52-Week Highs

    Benzinga
  34. Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma

    Benzinga
  35. Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium

    Benzinga
  36. Infinity Announces Closing of Public Offering and Exercise of ...

    Benzinga
  37. Stocks Hitting 52-Week Highs

    Benzinga
  38. Infinity Pharma Prices 5.696M Shares at $26.33

    Benzinga
  39. Mid-Afternoon Market Update: Markets Continue to Rise, Diamond ...

    Benzinga
  40. Infinity Pharma Shares Rebound Over $22 Following Phase I Data ...

    Benzinga
  41. UPDATE: Jefferies Downgrades Infinity Pharmaceuticals to Hold ...

    Benzinga
  42. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  43. Stocks Hitting 52-Week Highs

    Benzinga
  44. UPDATE: Stifel Nicolaus Initiates Infinity Pharmaceuticals at ...

    Benzinga
  45. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  46. Health Care Sector Wrap

    FoxBusiness
  47. Synacor, American Capital Mortgage Investment Crp, Other Stocks ...

    FoxBusiness
  48. Infinity Pharmaceuticals Shuts Down Cancer Trials

    Benzinga
  49. Morning Market Losers

    Benzinga
  50. Benzinga's Top Pre-Market Losers

    Benzinga
  51. A Peek Into The Market Before The Trading Starts

    Benzinga
  52. UPDATE: Piper Jaffray Lowers PT on Infinity Pharmaceuticals to ...

    Benzinga
  53. Infinity Plummets on Disappointing Phase 2 Study

    Benzinga
  54. Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8

    Benzinga
  55. Infinity Reports Update from Phase 2 Study of Saridegib Plus ...

    Benzinga
  56. Infinity Reports New Data from Phase 1b Trial of Saridegib in ...

    Benzinga
Trading Center